RaySearch Laboratories AB announced that version 4.0 of RaySearch's RayStation treatment planning system has been released for clinical use in several European countries, USA, Japan, Australia and New Zealand, and is scheduled for market release in Canada, China, and South Korea.

At RSNA 2013, Dome will feature its new LED backlight technology in the Dome S6c. It is a 30-inch, widescreen, 6 MP color display offering superb image quality and long product life.

Montage Healthcare Solutions, Inc., a provider of search-driven radiology analytics and data mining tools, announced that more than 27 healthcare organizations have added Montage Search and Analytics to their Nuance PowerScribe 360|Reporting workflow. By tightly integrating these solutions, radiologists can have more data in their hands to optimize decision-making during the dictation process. Montage Search and Analytics can be launched from within PowerScribe 360|Reporting, providing radiologists with clinical decision support through seamless access to historical reports.


A new analysis has found that most deaths from breast cancer occur in younger women who do not receive regular mammograms. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that regular screening before age 50 should be encouraged.


Since 2007, John Muir Health’s Clinical Research Center has been participating in a large-scale research project alongside dozens of other hospitals around the world as part of the International Early Lung Cancer Action Program (I-ELCAP) and has screened 250 patients to date. The study quantifies the benefits of low dose CT scans for early lung cancer detection in high-risk patients – current and former heavy smokers ages 55 to 80.

ClearCanvas introduces its new vendor neutral picture archive and communications system (PACS), Cleome, to its portfolio of commercial products. This Web-based breakthrough solution features fast diagnostic viewing of all medical images using zero-footprint HTML5, anytime, anywhere. 

Subscribe Now